To investigate the effect of proton pump inhibitor(PPI) treatment on salivary pepsin concentration in laryngopharyngeal reflux(LPR). 152 patients with suspected LPR complaining non-specific symptoms such as foreign body sensation, dry throat, phlegm and other non-specific symptoms were enrolled, in the Second Affiliated Hospital of Xi'an Jiaotong University from August 2019 to December 2020. According to the scores of reflux symptom index(RSI) and reflux finding score(RFS), all the patients were divided into LPR (+) group and LPR (-) group, RSI (+) group and RSI (-) group, RFS (+) group and RFS (-) group . Patients in the LPR (+) group were reassessed after 1 month of PPI treatment. Saliva samples were collected from all the patients at initial diagnosis and follow-up diagnosis after treatment. The salivary pepsin concentration was determined by enzyme linked immunosorbent assay (ELISA). The differences of RSI, RFS scores and salivary pepsin concentrations before and after treatment were compared. The median concentration of salivary pepsin in LPR (+) group was significantly higher than that in LPR (-) group, and (73.01 ng/mL vs 25.66 ng/mL, <0.01), the median concentration of salivary pepsin in RFS (+) group were significantly higher than that in RFS (-) group(78.00 ng/mL vs 35.79 ng/mL, <0.01) Furthermore, the median scores of RSI (11.00 vs 7.00, <0.05) and RFS (9.00 vs 7.00, <0.01) of LPR (+) patients notably decreased after PPI treatment for 1 month, and the salivary pepsin median concentration was memorably lower than that before treatment(53.60 ng/mL vs 46.49 ng/mL, <0.05). Meanwhile, the scores of symptoms such as pharyngeal paraesthesia, heartburn, chest pain, stomachache, and the scores of signs such as false vocal fold, erythema or congestion, vocal fold edema, posterior commissure hypertrophy and thick endolaryngeal mucus were conspicuously lower after treatment than those before treatment(<0.05). After 1 month of PPI treatment, the scores of partial symptoms and signs, and the salivary pepsin concentrations of LPR patients decreased significantly, suggesting that pepsin plays an important role in the pathogenesis of LPR, and pepsin may be closely related to the symptoms and signs such as pharyngeal paraesthesia and vocal fold edema.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128359PMC
http://dx.doi.org/10.13201/j.issn.2096-7993.2021.11.002DOI Listing

Publication Analysis

Top Keywords

salivary pepsin
20
(+) group
20
(-) group
16
pepsin concentration
12
lpr (+)
12
group
9
proton pump
8
treatment salivary
8
non-specific symptoms
8
lpr (-)
8

Similar Publications

Impact of the stepwise implementation of INFOGEST semi-dynamic conditions on in vitro starch and protein digestion: A case study on lentil cotyledon cells.

Food Res Int

December 2024

Laboratory of Food Technology, Department of Microbial and Molecular Systems (M2S), KU Leuven, Kasteelpark Arenberg 22, PB 2457, 3001 Leuven, Belgium. Electronic address:

The impact of food design parameters on digestion is mostly studied using static in vitro digestion models. In this work, the complexity of the static model was gradually increased, by implementing several dynamic gastric reactor conditions, i.e.

View Article and Find Full Text PDF

A biosensor based on carbon dots-protein interactions for specific and sensitive detection of pepsin in saliva.

Int J Biol Macromol

November 2024

School of Chemistry and Life Science, Changchun University of Technology, 2055 Yanan Street, Changchun 130012, PR China. Electronic address:

Article Synopsis
  • Salivary pepsin is identified as a promising biomarker for quickly screening and diagnosing gastroesophageal reflux disease (GERD), but traditional fluorescent sensors struggle in acidic conditions.
  • Researchers developed a new biosensor using green-emitting ionic liquid-based carbon dots (G-IL-CDs) linked with whey proteins (WPs), which improves pepsin detection by displaying enhanced fluorescence when aggregated.
  • The biosensor demonstrated high specificity for pepsin in human saliva by functioning effectively in an acidic environment, paving the way for future advancements in biosensor technology combining carbon dots and proteins.
View Article and Find Full Text PDF

The reflux symptom score has good screening value for laryngopharyngeal reflux.

BMC Gastroenterol

October 2024

Otorhinolaryngology Hospital, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China.

Article Synopsis
  • The study aimed to evaluate how consistent the reflux symptom score (RSS) is with a salivary pepsin test for diagnosing laryngopharyngeal reflux (LPR) by testing both methods on patients.
  • A total of 67 patients were assessed, revealing a high LPR positivity rate for both the salivary pepsin test (71.64%) and RSS (70.15%), with strong statistical agreement between the two tests.
  • The RSS demonstrated good diagnostic performance for LPR, indicated by a high sensitivity (89.58%) and a strong area under the curve in ROC analysis, suggesting it can effectively screen for LPR in patients.
View Article and Find Full Text PDF

Background And Purpose: The definitive diagnosis of gastroesophageal reflux disease (GERD) often requires invasive investigations like upper gastrointestinal endoscopy or reflux monitoring. We aimed to explore the relationship between salivary pepsin and GERD and its value as a non-invasive diagnostic tool.

Methods: Databases (PubMed, Web of Science, Cochran Library, and EMBASE) were searched from their inception to January 22, 2024 to explore the correlation of salivary pepsin with GERD.

View Article and Find Full Text PDF

Salivary pepsin testing for laryngopharyngeal reflux: will it change our management?

Curr Opin Otolaryngol Head Neck Surg

December 2024

Department of Surgery, University of Auckland, Auckland, New Zealand.

Article Synopsis
  • This review examines the potential clinical benefits of measuring pepsin in saliva and laryngopharyngeal tissue for diagnosing and treating laryngopharyngeal reflux (LPR).
  • Recent research indicates that salivary pepsin detection is a noninvasive way to identify LPR, but there is still debate about the best testing methods and timing for accurate results.
  • Although salivary pepsin detection shows promise for guiding treatment decisions, particularly with proton pump inhibitors, the exact diagnostic criteria and testing protocols remain unclear and may vary by location.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!